High expression of sphingosine 1-phosphate receptors, S1P1 and S1P3, sphingosine kinase 1, and extracellular signal-regulated kinase-1/2 is associated with development of tamoxifen resistance in estrogen receptor-positive breast cancer patients.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  American Journal of Pathology

• Publication date

  2010-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2353/ajpath.2010.100220PMID 20889557PMCID PMC2966780
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sphingosine 1-phosphate and cancer

  2010cited by this paper
• Sphingosine Kinase 1 Induces Tolerance to Human Epidermal Growth Factor Receptor 2 and Prevents Formation of a Migratory Phenotype in Response to Sphingosine 1-Phosphate in Estrogen Receptor-Positive Breast Cancer Cells

  2010cited by this paper
• ole of sphingolipids in the cytoplasmic signaling of estrogens

  2009cited by this paper
• strogen and progesterone interactive effects in postconfluent CF-7 cell culture

  2009cited by this paper
• Genetic Alterations and Oncogenic Pathways Associated with Breast Cancer Subtypes

  2009cited by this paper
• Restoring endocrine response in breast cancer cells by inhibition of the sphingosine kinase-1 signaling pathway.

  2009cited by this paper
• Ras/Raf-1/MAPK Pathway Mediates Response to Tamoxifen but not Chemotherapy in Breast Cancer Patients

  2009cited by this paper
• Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer.

  2009cited by this paper
• Sphingosine 1-phosphate, lysophosphatidic acid and growth factor signaling and termination.

  2008cited by this paper
• Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer

  2008influential reference
• ERBB2 influences the subcellular localization of the estrogen receptor in tamoxifen-resistant MCF-7 cells leading to the activation of AKT and RPS6KA2.

  2008cited by this paper
• Overview of resistance to systemic therapy in patients with breast cancer.

  2007cited by this paper
• Observer variation in immunohistochemical analysis of protein expression, time for a change?

  2006cited by this paper
• Estrogen transactivates EGFR via the sphingosine 1-phosphate receptor Edg-3: the role of sphingosine kinase-1

  2006influential reference
• Sphingosine 1-phosphate receptor expression profile in human gastric cancer cells: differential regulation on the migration and proliferation.

  2006cited by this paper
• Sphingosine 1-Phosphate Receptor Expression Profile in Human Gastric Cancer Cells: Differential Regulation on the Migration and Proliferation1

  2006cited by this paper
• Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer.

  2005cited by this paper
• Outcome and human epidermal growth factor receptor (HER) 1–4 status in invasive breast carcinomas with proliferation indices evaluated by bromodeoxyuridine labelling

  2004cited by this paper
• Sphingosine kinase transmits estrogen signaling in human breast cancer cells.

  2003cited by this paper
• Identification of functional nuclear export sequences in human sphingosine kinase 1.

  2003cited by this paper
• The Edg family G protein-coupled receptors for lysophospholipids: their signaling properties and biological activities.

  2002cited by this paper
• International Union of Pharmacology. XXXIV. Lysophospholipid Receptor Nomenclature

  2002cited by this paper
• The Multifaceted Mechanisms of Estradiol and Estrogen Receptor Signaling*

  2001cited by this paper
• Tethering of the platelet-derived growth factor beta receptor to G-protein-coupled receptors. A novel platform for integrative signaling by these receptor classes in mammalian cells.

  2001cited by this paper

• Targeting Sphingolipids in Breast Cancer: From Tumor Biology to Therapeutic Strategies

  2026cites this paper
• Sphingolipid metabolism-related genes B4GALNT1 and CERS4 as prognostic biomarkers in lung adenocarcinoma

  2026cites this paper
• Integration of summary data from GWAS and eQTLs studies predicts causality of S1PR1 and breast cancer

  2025cites this paper
• Targeting Sphingosine-1-Phosphate Signaling in Breast Cancer

  2024cites this paper
• Metabolomics analysis reveals resembling metabolites between humanized γδ TCR mice and human plasma

  2024cites this paper
• S1P1 Threonine 236 Phosphorylation Mediates the Invasiveness of Triple-Negative Breast Cancer and Sensitivity to FTY720

  2023cites this paper
• The lipid metabolism remodeling: A hurdle in breast cancer therapy.

  2023cites this paper
• Increased Sphingosine Kinase 1 Expression Is Associated with Poor Prognosis in Human Solid Tumors: A Meta-Analysis

  2022influential citation
• Clinical relevance of CERK and SPHK1 in breast cancer and their association with metastasis and drug resistance

  2022cites this paper
• Expression of sphingosine-1-phosphate receptor 2 is correlated with migration and invasion of human colon cancer cells: A preliminary clinical study

  2022cites this paper
• Transforming Growth Factor Beta Promotes the Expansion of Cancer Stem Cells via S1PR3 by Ligand-Independent Notch Activation.

  2022cites this paper
• Targeting metabolism: A potential strategy for hematological cancer therapy

  2022cites this paper
• Phase 1 Evaluation of 11C-CS1P1 to Assess Safety and Dosimetry in Human Participants

  2022cites this paper
• Structural insights into sphingosine-1-phosphate receptor activation

  2022cites this paper
• Plasma Sphingosine-1-Phosphate Levels Are Associated with Progression of Estrogen Receptor-Positive Breast Cancer

  2021cites this paper
• Sphingosine Kinase 1 Signaling in Breast Cancer: A Potential Target to Tackle Breast Cancer Stem Cells

  2021cites this paper
• Lysophosphatidate Promotes Sphingosine 1-Phosphate Metabolism and Signaling: Implications for Breast Cancer and Doxorubicin Resistance

  2021cites this paper
• A Novel Radioimmune 99mTc-Labeled Tracer for Imaging Sphingosine 1-Phosphate Receptor 1 in Tumor Xenografts: An In Vitro and In Vivo Study

  2021cites this paper
• Loss of sphingosine kinase 1 increases lung metastases in the MMTV-PyMT mouse model of breast cancer

  2021cites this paper
• Silencing of Sphingosine 1-Phosphate Receptors and Potassium Channels May Inhibits the Invasion and Migration of Breast Cancer

  2021cites this paper
• A Glimpse of the Structural Biology of the Metabolism of Sphingosine-1-Phosphate

  2021cites this paper
• A new model for regulation of sphingosine kinase 1 translocation to the plasma membrane in breast cancer cells

  2021cites this paper
• Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention.

  2020cites this paper
• Sphingosine Kinase 1 Regulates the Survival of Breast Cancer Stem Cells and Non-stem Breast Cancer Cells by Suppression of STAT1

  2020cites this paper
• Sphingosine Kinase 1 in Breast Cancer—A New Molecular Marker and a Therapy Target

  2020cites this paper
• Targeting G protein-coupled receptors in cancer therapy.

  2020cites this paper
• Structure-function analysis of lipid substrates and inhibitors of sphingosine kinases.

  2020cites this paper
• Lipid Phosphate Phosphatases and Cancer

  2020cites this paper
• Sphingosine-1-Phosphate: Its Pharmacological Regulation and the Treatment of Multiple Sclerosis: A Review Article

  2020cites this paper
• Interleukin-22 Mediates the Chemotactic Migration of Breast Cancer Cells and Macrophage Infiltration of the Bone Microenvironment by Potentiating S1P/SIPR Signaling

  2020cites this paper
• Recent advances in the role of sphingosine 1‐phosphate in cancer

  2020cites this paper
• S1P Signaling in the Tumor Microenvironment.

  2020cites this paper
• Bioactive sphingolipids: Advancements and contributions from the laboratory of Dr. Lina M. Obeid

  2020cites this paper
• Acute Rodent Tolerability, Toxicity, and Radiation Dosimetry Estimates of the S1P1-Specific Radioligand [11C]CS1P1

  2019cites this paper
• Sphingosine-1-phosphate signaling: A novel target for simultaneous adjuvant treatment of triple negative breast cancer and chemotherapy-induced neuropathic pain.

  2019cites this paper
• Roles of sphingosine-1-phosphate signaling in cancer

  2019cites this paper
• S1P/S1P Receptor Signaling in Neuromuscolar Disorders

  2019cites this paper
• Curbing Lipids: Impacts ON Cancer and Viral Infection

  2019cites this paper
• Pharmacological Inhibition of Serine Palmitoyl Transferase and Sphingosine Kinase-1/-2 Inhibits Merkel Cell Carcinoma Cell Proliferation.

  2019cites this paper
• ESKİŞEHİR TEKNİK ÜNİVERSİTESİ BİLİM VE TEKNOLOJİ DERGİSİ C- YAŞAM BİLİMLERİ VE BİYOTEKNOLOJİ

  2019cites this paper
• A Designed Small Molecule Inhibitor of a Non-Coding RNA Sensitizes HER2 Negative Cancers to Herceptin.

  2019cites this paper
• The sphingosine 1-phosphate receptor 2 is shed in exosomes from breast cancer cells and is N-terminally processed to a short constitutively active form that promotes extracellular signal regulated kinase activation and DNA synthesis in fibroblasts

  2019cites this paper
• Sphingosine 1–phosphate signaling induces SNAI2 expression to promote cell invasion in breast cancer cells

  2019cites this paper
• (2018) Does the sphingosine 1-phosphate receptor-1 provide a better or worse prognostic outcome for breast cancer patients? Frontiers

  2019cites this paper
• The role of tumor suppressor p53 in metabolism and energy regulation, and its implication in cancer and lifestyle-related diseases.

  2019cites this paper
• Bioactive lysolipids in cancer and angiogenesis.

  2019cites this paper
• S1PR1 as a Novel Promising Therapeutic Target in Cancer Therapy

  2019cites this paper
• MCT-17-1141 289..300

  2019cites this paper
• Activation of sphingosine kinase by lipopolysaccharide promotes prostate cancer cell invasion and metastasis via SphK1/S1PR4/matriptase

  2019cites this paper
• Expansion of Sphingosine Kinase and Sphingosine-1-Phosphate Receptor Function in Normal and Cancer Cells: From Membrane Restructuring to Mediation of Estrogen Signaling and Stem Cell Programming

  2018influential citation
• PathCORE-T: identifying and visualizing globally co-occurring pathways in large transcriptomic compendia

  2018cites this paper
• Syntheses and in vitro biological evaluation of S1PR1 ligands and PET studies of four F-18 labeled radiotracers in the brain of nonhuman primates.

  2018cites this paper
• The sphingosine 1-phosphate receptor 2 is shed in exosomes from breast cancer cells and is N-terminally processed to a short constitutively active form that promotes extracellular signal regulated kinase activation and DNA synthesis in fibroblasts

  2018cites this paper
• Targeting lipid mediators in cancer biology

  2018cites this paper
• Does the Sphingosine 1-Phosphate Receptor-1 Provide a Better or Worse Prognostic Outcome for Breast Cancer Patients?

  2018cites this paper
• Sphingosine kinase 1 activation by estrogen receptor α36 contributes to tamoxifen resistance in breast cancer

  2018cites this paper
• Targeting the Sphingosine 1-Phosphate Axis Exerts Potent Antitumor Activity in BRAFi-Resistant Melanomas

  2018influential citation
• Deletion of sphingosine kinase 1 inhibits liver tumorigenesis in diethylnitrosamine-treated mice

  2018cites this paper
• Sphingolipidomics analysis of large clinical cohorts. Part 2: Potential impact and applications.

  2018cites this paper
• Fingolimod interrupts the cross talk between estrogen metabolism and sphingolipid metabolism within prostate cancer cells.

  2018cites this paper
• GPCRs: Emerging anti-cancer drug targets.

  2018cites this paper
• Sphingosine Kinases as Druggable Targets.

  2018cites this paper
• ABCC1-Exported Sphingosine-1-phosphate, Produced by Sphingosine Kinase 1, Shortens Survival of Mice and Patients with Breast Cancer

  2018cites this paper
• Survival benefit of sphingosin‐1‐phosphate and receptors expressions in breast cancer patients

  2018cites this paper
• Targeting Sphingosine Kinase Isoforms Effectively Reduces Growth and Survival of Neoplastic Mast Cells With D816V-KIT

  2018cites this paper
• S1P/S1PR3 axis promotes aerobic glycolysis by YAP/c-MYC/PGAM1 axis in osteosarcoma

  2018cites this paper
• Bioactive Sphingolipids as Biomarkers Predictive of Disease Severity and Treatment Response in Cancer: Current Status and Translational Challenges

  2018cites this paper
• GPCR Modulation in Breast Cancer

  2018cites this paper
• Mammalian sphingosine kinase (SphK) isoenzymes and isoform expression: challenges for SphK as an oncotarget

  2017influential citation
• Targeting sphingosine-1-phosphate signaling for cancer therapy

  2017cites this paper
• The sphingosine 1-phosphate receptor modulator fingolimod as a therapeutic agent: Recent findings and new perspectives.

  2017cites this paper
• Clinical Impact of Sphingosine-1-Phosphate in Breast Cancer

  2017cites this paper
• Oncogenic S1P signalling in EBV‐associated nasopharyngeal carcinoma activates AKT and promotes cell migration through S1P receptor 3

  2017cites this paper
• Exploring and Characterizing the Conformational Space of the A2AAR and the S1PR1 for the Treatment of Immunological Disorders

  2017cites this paper
• Développement d'un capteur à base de polymère à empreintes moléculaires pour la quantification de la sphingosine 1-phosphate libre et circulante comme biomarqueur du mélanome cutané

  2017cites this paper
• Sphingosine kinase 1 in breast cancer.

  2017cites this paper
• Sphingosine 1-Phosphate Receptor 1 Signaling in Mammalian Cells

  2017cites this paper
• Implication of sphingosine-1-phosphate signaling in diseases: molecular mechanism and therapeutic strategies

  2017cites this paper
• Modulation of sphingosine-1-phosphate in inflammatory bowel disease.

  2017cites this paper
• Therapeutic Strategies and Pharmacological Tools Influencing S1P Signaling and Metabolism

  2017cites this paper
• 1 ROLE OF SPHINGOSINE 1-PHOSPHATE RECEPTORS , SPHINGOSINE KINASES AND SPHINGOSINE IN CANCER AND INFLAMMATION

  2017cites this paper
• PathCORE: identifying and visualizing globally co-occurring pathways in large transcriptomic compendia

  2017cites this paper
• On the role of bioactive sphingolipids and their metabolizing enzymes in cancer

  2017cites this paper
• Effects of S1P1 and S1P3 in ER+ and ER- Breast Cancer Cells.

  2017cites this paper
• Sphingosine 1-phosphate and cancer.

  2017cites this paper
• “Dicing and Splicing” Sphingosine Kinase and Relevance to Cancer

  2017cites this paper
• A role for caspase‐2 in sphingosine kinase 1 proteolysis in response to doxorubicin in breast cancer cells – implications for the CHK1‐suppressed pathway

  2017cites this paper
• Insulin-like growth factor receptor and sphingosine kinase are prognostic and therapeutic targets in breast cancer

  2017cites this paper
• Mechanisms of sphingosine 1-phosphate receptor signalling in cancer.

  2017cites this paper
• Sphingosine 1-Phosphate (S1P) Signaling in Glioblastoma Multiforme—A Systematic Review

  2017cites this paper
• Melatonin prevents deregulation of the sphingosine kinase/sphingosine 1‐phosphate signaling pathway in a mouse model of diethylnitrosamine‐induced hepatocellular carcinoma

  2017cites this paper
• Molecular mechanisms of target recognition by lipid GPCRs: relevance for cancer

  2016cites this paper
• To fingolimod and beyond: The rich pipeline of drug candidates that target S1P signaling.

  2016cites this paper
• Benzyl butyl phthalate promotes breast cancer stem cell expansion via SPHK1/S1P/S1PR3 signaling

  2016cites this paper
• The emerging role of FTY720 (Fingolimod) in cancer treatment

  2016cites this paper
• Sphingosine-1 Phosphate: A New Modulator of Immune Plasticity in the Tumor Microenvironment

  2016cites this paper
• Effects of chemotherapy agents on Sphingosine-1-Phosphate receptors expression in MCF-7 mammary cancer cells.

  2016cites this paper
• Therapeutic potential of targeting sphingosine kinases and sphingosine 1-phosphate in hematological malignancies

  2016cites this paper
• Role of sphingosine 1-phosphate receptors, sphingosine kinases and sphingosine in cancer and inflammation.

  2016cites this paper
• Sphingosine-1-phosphate and estrogen signaling in breast cancer.

  2016cites this paper